tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Cerevel Therapeutics Holdings's activity chart (see below) currently has 71 price targets and 52 ratings on display.
Analysts average stock forecasts to be materialized ratio is 58.46% with an average time for these price targets to be met of 123.42 days.
Most recent stock forecast was given by from MIZUHO on 16-Feb-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Jul-2022
$45
$0.04 (0.09%)
$25
2 years 7 months 22 days ago
(16-Feb-2024)
8/10 (80%)
$2.43 (5.71%)
66
Hold Since 20-Nov-2023
$45
$0.04 (0.09%)
$25
2 years 9 months 10 days ago
(28-Dec-2023)
3/4 (75%)
$2.56 (6.03%)
136
Buy Since 23-Nov-2020
$45
$0.04 (0.09%)
$37
2 years 9 months 16 days ago
(22-Dec-2023)
3/4 (75%)
$3.1 (7.40%)
76
Hold Since 08-Dec-2023
$45
$0.04 (0.09%)
2 years 10 months ago
(08-Dec-2023)
0/1 (0%)
$3.78 (9.17%)
Buy Since 28-Sep-2023
$33
$-11.96 (-26.60%)
2 years 10 months 1 days ago
(07-Dec-2023)
1/2 (50%)
$-8.13 (-19.77%)
69
What is CERE (Cerevel Therapeutics Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on CERE (Cerevel Therapeutics Holdings)?
Which analyst has the most public recommendations on CERE (Cerevel Therapeutics Holdings)?
Which analyst is the currently most bullish on CERE (Cerevel Therapeutics Holdings)?
Which analyst is the currently most reserved on CERE (Cerevel Therapeutics Holdings)?
